JP Morgan Chase
BNTX icon

JP Morgan Chase’s BioNTech BNTX Stock Holding History

JP Morgan Chase’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
126,975
+9,707
+8% +$914K ﹤0.01% 2649
2026
Q1 		$10M Buy
117,268
+4,571
+4% +$470K ﹤0.01% 2670
2025
Q4 		$10.7M Buy
112,697
+52,541
+87% +$5.29M ﹤0.01% 2609
2025
Q3 		$5.93M Sell
60,156
-4,618
-7% -$494K ﹤0.01% 3193
2025
Q2 		$6.9M Buy
64,774
+63,002
+3,555% +$6.36M ﹤0.01% 2868
2025
Q1 		$161K Sell
1,772
-8,318
-82% -$931K ﹤0.01% 5337
2024
Q4 		$1.15M Sell
10,090
-16,613
-62% -$1.9M ﹤0.01% 4539
2024
Q3 		$3.17M Sell
26,703
-23,016
-46% -$2.12M ﹤0.01% 3592
2024
Q2 		$4M Buy
49,719
+42,123
+555% +$3.85M ﹤0.01% 3214
2024
Q1 		$701K Sell
7,596
-231
-3% -$22.1K ﹤0.01% 4581
2023
Q4 		$826K Buy
7,827
+7,057
+916% +$711K ﹤0.01% 4465
2023
Q3 		$83.7K Buy
770
+162
+27% +$17.9K ﹤0.01% 5593
2023
Q2 		$65.6K Sell
608
-24,347
-98% -$2.74M ﹤0.01% 5640
2023
Q1 		$3.11M Sell
24,955
-2,029
-8% -$279K ﹤0.01% 3188
2022
Q4 		$4.05M Buy
26,984
+11,365
+73% +$1.75M ﹤0.01% 3003
2022
Q3 		$2.11M Sell
15,619
-2,882
-16% -$441K ﹤0.01% 3417
2022
Q2 		$2.76M Sell
18,501
-1,711
-8% -$261K ﹤0.01% 3293
2022
Q1 		$3.45M Sell
20,212
-18,902
-48% -$3.18M ﹤0.01% 3318
2021
Q4 		$10.1M Buy
39,114
+3,103
+9% +$850K ﹤0.01% 2456
2021
Q3 		$9.83M Buy
36,011
+3,567
+11% +$1.13M ﹤0.01% 2399
2021
Q2 		$7.26M Buy
32,444
+10,435
+47% +$1.97M ﹤0.01% 2711
2021
Q1 		$2.4M Sell
22,009
-33,723
-61% -$3.58M ﹤0.01% 3577
2020
Q4 		$4.54M Buy
55,732
+2,735
+5% +$268K ﹤0.01% 2888
2020
Q3 		$3.54M Buy
52,997
+28,849
+119% +$2.07M ﹤0.01% 2833
2020
Q2 		$1.61M Buy
24,148
+24,098
+48,196% +$1.2M ﹤0.01% 3242
2020
Q1 		$3K Buy
+50
New +$1.95K ﹤0.01% 5153

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

JP Morgan Chase's BNTX Position: Q2 2026 in Review

JP Morgan Chase increased its BioNTech (BNTX) stake by 8.3% in Q2 2026, buying an estimated $914K and bringing the position to 126,975 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

JP Morgan Chase first reported a position in BNTX in Q1 2020 and has held it in 26 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • JP Morgan Chase held 126,975 shares of BioNTech worth $12M as of Q2 2026.
  • JP Morgan Chase bought 9,707 BioNTech shares in Q2 2026, an estimated $914K.
  • BioNTech made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2649 holding.
  • JP Morgan Chase first reported a position in BioNTech in Q1 2020 and has held it in 26 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.